Treatment

Liposomal Annamycin clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase 1/2 Study of Liposomal Annamycin in Combination with Cytarabine for the Treatment of Subjects with Acute Myeloid Leukemia (AML).
This study is looking at a new combination treatment for acute myeloid leukemia (AML), a type of blood cancer. It combines a new drug, Liposomal Annamycin, with a standard treatment, cytarabine. Researchers want to see if this new combination is safe and effective.
For: Acute Myeloid Leukemia
Poland · Italy
Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase 1b/2 study of liposomal annamycin (l-annamycin) in patients with previously treated metastatic soft-tissue sarcomas (ANNA-SARC)
This study is looking at a new treatment called liposomal annamycin for advanced soft-tissue sarcomas that haven't responded to previous treatments. It aims to find the right dose and see how well it stops the cancer from growing.
For: METASTATIC SOFT-TISSUE SARCOMAS AFTER FAILURE ON AT LEAST ONE SYSTEMIC THERAPY
Poland